IGM Biosciences, Inc. (IGMS)

IGM Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 6, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	79	363	485	728	952	2,818
Market Cap Growth	-87.88%	-25.13%	-33.39%	-23.49%	-66.22%	141.87%
Enterprise Value	-31	190	139	287	722	2,651
Last Close Price	1.24	6.11	8.31	17.01	29.33	88.29
PS Ratio	28.11	135.62	227.82	681.46	-	-
PB Ratio	106.69	7.54	2.39	2.54	3.89	7.38
P/TBV Ratio	111.10	7.54	2.39	2.54	3.89	7.38
EV/Sales Ratio	-	71.07	65.47	268.87	-	-
Debt / Equity Ratio	62.98	0.94	0.20	0.14	0.12	0.03
Asset Turnover	0.01	0.01	0.01	0.00	-	-
Quick Ratio	5.43	4.90	7.97	9.57	8.26	21.25
Current Ratio	5.71	5.14	8.18	9.81	8.67	21.65
Return on Equity (ROE)	-245.59%	-155.76%	-100.48%	-83.09%	-52.71%	-26.16%
Return on Assets (ROA)	-36.78%	-35.23%	-34.91%	-35.11%	-29.24%	-15.54%
Return on Capital (ROIC)	-86.87%	-72.02%	-57.16%	-47.33%	-30.95%	-16.04%
Earnings Yield	-256.45%	-53.89%	-50.78%	-30.35%	-17.35%	-2.89%
FCF Yield	-188.91%	-43.72%	-42.17%	-2.20%	-14.52%	-3.03%
Buyback Yield / Dilution	-8.10%	-15.68%	-25.92%	-24.09%	-8.88%	-241.82%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q